1st Quarter - Report
PURDUE PHARMA, LP for PURDUE PHARMA LP
Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND New | — |
| BURT E ROSEN | — |
Alcohol and Drug Abuse ALC
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND New | — |
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.